Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry: Catheterization and Cardiovascular Interventions

J Nicolas; BE Claessen; D Cao; S Sartori; U Baber; D Power; M Chiarito; R Goel; A Roumeliotis; R Chandiramani; S Chen; J Chandrasekhar; D Tchetche; AS Petronio; J Mehilli; T Lefèvre; P Presbitero; P Capranzano; A Iadanza; G Sardella; NM Van Mieghem; E Meliga; N Dumonteil; C Fraccaro; D Trabattoni; G Mikhail; MC Ferrer-Gracia; C Naber; S Sharma; MC Morice; GD Dangas; A Chieffo; R Mehran

doi:10.1002/ccd.29276

Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry: Catheterization and Cardiovascular Interventions

J Nicolas, BE Claessen, D Cao, S Sartori, U Baber, D Power, M Chiarito, R Goel, A Roumeliotis, R Chandiramani, S Chen, J Chandrasekhar, D Tchetche, AS Petronio, J Mehilli, T Lefèvre, P Presbitero, P Capranzano, A Iadanza, G SardellaNM Van Mieghem, E Meliga, N Dumonteil, C Fraccaro, D Trabattoni, G Mikhail, MC Ferrer-Gracia, C Naber, S Sharma, MC Morice, GD Dangas, A Chieffo, R Mehran

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: To assess the impact of anemia on clinical outcomes in female patients enrolled in the Women's InterNational transcatheter aortic valve implantation (WIN-TAVI) registry. Background: Anemia is highly prevalent among females who constitute half of TAVI candidates, yet, its clinical significance remains poorly investigated. Methods: Patients were divided into three groups according to preprocedural hemoglobin (Hb) level: (1) no anemia (Hb ≥12 g/dl), (2) mild-to-moderate anemia (10 ≤ Hb

Original language	English
Pages (from-to)	E704-E715
Journal	Catheter. Cardiovasc. Interventions
Volume	97
Issue number	5
DOIs	https://doi.org/10.1002/ccd.29276
Publication status	Published - 2021

Access to Document

10.1002/ccd.29276

Cite this

Nicolas, J., Claessen, BE., Cao, D., Sartori, S., Baber, U., Power, D., Chiarito, M., Goel, R., Roumeliotis, A., Chandiramani, R., Chen, S., Chandrasekhar, J., Tchetche, D., Petronio, AS., Mehilli, J., Lefèvre, T., Presbitero, P., Capranzano, P., Iadanza, A., ... Mehran, R. (2021). Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry: Catheterization and Cardiovascular Interventions. Catheter. Cardiovasc. Interventions, 97(5), E704-E715. https://doi.org/10.1002/ccd.29276

Nicolas, J, Claessen, BE, Cao, D, Sartori, S, Baber, U, Power, D, Chiarito, M, Goel, R, Roumeliotis, A, Chandiramani, R, Chen, S, Chandrasekhar, J, Tchetche, D, Petronio, AS, Mehilli, J, Lefèvre, T, Presbitero, P, Capranzano, P, Iadanza, A, Sardella, G, Van Mieghem, NM, Meliga, E, Dumonteil, N, Fraccaro, C, Trabattoni, D, Mikhail, G, Ferrer-Gracia, MC, Naber, C, Sharma, S, Morice, MC, Dangas, GD, Chieffo, A & Mehran, R 2021, 'Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry: Catheterization and Cardiovascular Interventions', Catheter. Cardiovasc. Interventions, vol. 97, no. 5, pp. E704-E715. https://doi.org/10.1002/ccd.29276

@article{6ca5085181e74b22805efddaed58bffd,

title = "Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry: Catheterization and Cardiovascular Interventions",

abstract = "Objectives: To assess the impact of anemia on clinical outcomes in female patients enrolled in the Women's InterNational transcatheter aortic valve implantation (WIN-TAVI) registry. Background: Anemia is highly prevalent among females who constitute half of TAVI candidates, yet, its clinical significance remains poorly investigated. Methods: Patients were divided into three groups according to preprocedural hemoglobin (Hb) level: (1) no anemia (Hb ≥12 g/dl), (2) mild-to-moderate anemia (10 ≤ Hb ",

author = "J Nicolas and BE Claessen and D Cao and S Sartori and U Baber and D Power and M Chiarito and R Goel and A Roumeliotis and R Chandiramani and S Chen and J Chandrasekhar and D Tchetche and AS Petronio and J Mehilli and T Lef{\`e}vre and P Presbitero and P Capranzano and A Iadanza and G Sardella and {Van Mieghem}, NM and E Meliga and N Dumonteil and C Fraccaro and D Trabattoni and G Mikhail and MC Ferrer-Gracia and C Naber and S Sharma and MC Morice and GD Dangas and A Chieffo and R Mehran",

year = "2021",

doi = "10.1002/ccd.29276",

language = "English",

volume = "97",

pages = "E704--E715",

journal = "Catheter. Cardiovasc. Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry

T2 - Catheterization and Cardiovascular Interventions

AU - Nicolas, J

AU - Claessen, BE

AU - Cao, D

AU - Sartori, S

AU - Baber, U

AU - Power, D

AU - Chiarito, M

AU - Goel, R

AU - Roumeliotis, A

AU - Chandiramani, R

AU - Chen, S

AU - Chandrasekhar, J

AU - Tchetche, D

AU - Petronio, AS

AU - Mehilli, J

AU - Lefèvre, T

AU - Presbitero, P

AU - Capranzano, P

AU - Iadanza, A

AU - Sardella, G

AU - Van Mieghem, NM

AU - Meliga, E

AU - Dumonteil, N

AU - Fraccaro, C

AU - Trabattoni, D

AU - Mikhail, G

AU - Ferrer-Gracia, MC

AU - Naber, C

AU - Sharma, S

AU - Morice, MC

AU - Dangas, GD

AU - Chieffo, A

AU - Mehran, R

PY - 2021

Y1 - 2021

N2 - Objectives: To assess the impact of anemia on clinical outcomes in female patients enrolled in the Women's InterNational transcatheter aortic valve implantation (WIN-TAVI) registry. Background: Anemia is highly prevalent among females who constitute half of TAVI candidates, yet, its clinical significance remains poorly investigated. Methods: Patients were divided into three groups according to preprocedural hemoglobin (Hb) level: (1) no anemia (Hb ≥12 g/dl), (2) mild-to-moderate anemia (10 ≤ Hb

AB - Objectives: To assess the impact of anemia on clinical outcomes in female patients enrolled in the Women's InterNational transcatheter aortic valve implantation (WIN-TAVI) registry. Background: Anemia is highly prevalent among females who constitute half of TAVI candidates, yet, its clinical significance remains poorly investigated. Methods: Patients were divided into three groups according to preprocedural hemoglobin (Hb) level: (1) no anemia (Hb ≥12 g/dl), (2) mild-to-moderate anemia (10 ≤ Hb

U2 - 10.1002/ccd.29276

DO - 10.1002/ccd.29276

M3 - Article

SN - 1522-1946

VL - 97

SP - E704-E715

JO - Catheter. Cardiovasc. Interventions

JF - Catheter. Cardiovasc. Interventions

IS - 5

ER -

Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry: Catheterization and Cardiovascular Interventions

Abstract

Access to Document

Fingerprint

Cite this